World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2016
Main ID:  NCT02964286
Date of registration: 31/10/2016
Prospective Registration: No
Primary sponsor: Taipei Medical University
Public title: The Effect of Acupoint Massotherapy on Relieving Chemotherapy-induced Myelosupression
Scientific title: The Effect of Acupoint Massotherapy on Relieving Chemotherapy-induced Myelosupression Among Patients With Cancer
Date of first enrolment: July 2015
Target sample size: 200
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02964286
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care  
Phase:  N/A
Countries of recruitment
Taiwan
Contacts
Name:     Ya-Wen Shih, MSc
Address: 
Telephone: 0978986983
Email: stacy0419@hotmail.com
Affiliation: 
Name:     Wen-Chi Liu, MSc
Address: 
Telephone: 02-227372181
Email: 116085@tmuh.org.tw
Affiliation: 
Name:     Hsiu-Ting Tsai, PhD
Address: 
Telephone:
Email:
Affiliation:  Taipei Medical University
Key inclusion & exclusion criteria

Inclusion Criteria:

- newly diagnosed of gynecologic cancer, regardless of stage.

- receiving initial chemotherapy.

- ability to write informed consent.

- between 20 to 70 years old.

Exclusion Criteria:

- history of severe cardiac disorder.

- suffering from the hematological diseases such as hemolytic anemia.

- cancer patients with lymphoedema at the area of the acupressure points.

- diagnosed combine with other cancers.



Age minimum: 20 Years
Age maximum: 70 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Acupressure
Cancer, Breast
Hematopoiesis
Intervention(s)
Device: The Electric vibrating massager,SAMPO®
Primary Outcome(s)
The Effect of Acupoint Massotherapy on Relieving Chemotherapy-induced Myelosuppression Among Patients With Cancer. [Time Frame: Two years]
Secondary Outcome(s)
Secondary ID(s)
TMU-JIRB: 201501030
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history